Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform
Glycotope and Evotec enter licensing agreement to combine Glycotope antibodies and Evotec’s immune cell engager platform
New Asia-Pacific Hub Strengthens Singaporean MedTech Ecosystem
- Guaranteed portion of the transaction will extend cash runway past
regulatory milestones in Q1-2024
- The financial visibility will allow TME Pharma to file and receive
feedback from FDA on its IND and applications to expedited regulatory …
From 2024, the Federal Government and the State of Berlin will fund the establishment of the National Center for Tumor Diseases (NCT) Berlin. The new site is a cooperation between DKFZ and Charité, BIH, and Max Delbrück Center aimed at closely…
Investment part of billion-dollar investment program / Commitment to Berlin as an innovation hub / Governing Mayor of Berlin, Kai Wegner, inaugurates new facility together with Bayer Board Member Stefan Oelrich / New facility equipped with…
Treating cancer is becoming increasingly complex, but also offers more and more possibilities. After all, the better a tumor’s biology and genetic features are understood, the more treatment approaches there are. To be able to offer patients…
Unlike humans, zebrafish can completely regenerate their hearts after injury. They owe this ability to the interaction between their nervous and immune systems, as researchers led by Suphansa Sawamiphak from the Max Delbrück Center now report in the…
Blood cancer is often driven by mutations in stem cells, which are key target cells in the search for innovative early-stage therapies. Dr. Simon Haas, head of a lab within the joint research focus of the Berlin Institute of Health at Charité (BIH),…
World Health Summit – Catalyst and think tank for global health
Eckert & Ziegler (ISIN DE0005659700) strengthens its competitive position in the growth market of China and today signed a 50:50 joint venture agreement with the Chinese pharmaceutical company DongCheng Pharma (DC Pharma).